Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, giving promising breakthroughs across numerous medical and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer